SOPHiA GENETICS S.A.

NASDAQ:SOPH

Medical - Healthcare Information Services

Healthcare
$7.47 +0.38%

+$0.02 today

Market cap
$635.90M
Beta
0.98
P/E (TTM)
-4.6
EPS (TTM)
-$1.14
52W Low $2.59High $5.70

Volume 0.61M

Average 0.10M

SOPH Accounts Payables

Cash effect of the change in amounts owed to suppliers; growing payables preserve cash.

SOPHiA GENETICS S.A.NASDAQ: SOPH

Accounts Payables · Q1 FY2026 · quarter ended Mar 2026

Accounts payables turns negative

Q1 FY2026 accounts payables was -$3.28M, compared with $813K a year earlier. Trailing-twelve-month accounts payables was $12.45M.

Context

  • Accounts payables amounted to 21.9% of revenue in FY2025, up 10.6 pp from a year earlier.
  • Accounts payables increased in 2 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly accounts payables holds near -$3.28M or moves back toward the trailing-twelve-month quarterly average of $3.11M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$3.28M-123.9% QoQ
Last fiscal yearDec 2025
$16.93M+329.2% YoY
LTMMar 2026
$12.45M+595.4% YoY
Accounts Payables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-502.8%——
1 year+329.2%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Accounts Payables history

USD · from the cash flow

Latest · FY2025
16.93M USD
Year-over-year change
+329.2%
4-year CAGR
+17.2%

Accounts Payables vs competitors

How SOPH compares with its peers on the latest reported figures

  • SOPH's LTM Mar 2026 accounts payables of $12.45M is the largest of the 10 companies compared; the peer median is $1.73M.
  • Its year-over-year change of +595.4% is the highest of 9, against a peer median of +100.9%.
  • Accounts payables amounts to 15.3% of revenue for SOPH, versus a peer median of 0.8%.
SOPH Competitors Peer median
Accounts Payables for SOPH and competitors
Company Period LTM YoY 3-year CAGR% of revenue
SOPHSOPHiA GENETICS S.A.LTM Mar 2026$12.45M +595.4%—15.3%
TEMTempus AI, Inc.LTM Sep 2026$11.29M +164.1%-2.9%0.7%
CERTCertara, Inc.LTM Mar 2026$10.67M +138.4%—2.5%
DHDefinitive Healthcare Corp.LTM Mar 2026$3.92M -34.4%—1.6%
BLLNBillionToOne, Inc.LTM Jun 2026$3.33M ——0.8%
OPRXOptimizeRx CorporationLTM Mar 2026$2.71M +69.8%—2.5%
HSTMHealthStream, Inc.LTM Mar 2026$2.17M +132.1%—0.7%
PSNLPersonalis, Inc.LTM Mar 2026$1.73M +235.6%+13.8%2.7%
NRCNational Research CorporationLTM Mar 2026$485K -27.6%—0.3%
HCATHealth Catalyst, Inc.LTM Mar 2026$91K -97.7%+34.8%0.0%
Peer median (excluding SOPH) $1.73M+100.9%+13.8%0.8%

Competitors are the stored peer set for SOPH. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(73.51M)(87.59M)(78.5M)(61.27M)(79M)
Depreciation & Amortization3.61M5.57M8.34M8.6M9.53M
Deferred Income Tax(1.6M)(1.29M)(1.13M)(726K)0
Stock-Based Compensation8.51M13.61M15.24M16.49M0
Change in Working Capital6.12M(1.27M)872K(2.58M)10.71M
Accounts Receivables1.81M1.33M(6.5M)5.89M(6.6M)
Inventory(2.34M)(200K)(874K)69K46K
Accounts Payables8.98M(1.43M)6.87M(7.39M)16.93M
Other Working Capital(2.33M)(977K)1.38M(1.16M)334K
Other Non-Cash Items(1.08M)873K6.6M(3.33M)20.75M
Operating Cash Flow(57.94M)(70.09M)(48.58M)(42.82M)(38.01M)
Capital Expenditures(6.67M)(10.38M)(9.23M)(8.18M)(574K)
Acquisitions (Net)3.99M0000
Purchases of Investments(72.14M)(26.18M)00(1.89M)
Sales of Investments21.88M78.53M17.55M00
Other Investing Activities(3.99M)(6.28M)(7.73M)(7.93M)0
Investing Cash Flow(56.93M)41.97M8.32M(8.18M)(10.51M)
Debt Repayment(4.09M)(2.32M)(3.04M)11.18M32.69M
Common Stock Issued231.31M00405K1.44M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities10.55M748K226K00
Financing Cash Flow237.77M(1.57M)(2.82M)11.59M34.13M
Effect of Forex Changes(4.56M)(1.97M)5.02M(3.61M)4.45M
Net Change in Cash118.34M(31.66M)(38.05M)(43.03M)(9.94M)
Free Cash Flow(64.61M)(80.47M)(57.8M)(51M)(38.59M)

SOPHiA GENETICS S.A.

NASDAQ:SOPH

Intrinsic Alpha fair value

Locked

Current Price

$7.47

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.